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Introduction
Facioscapulohumeral muscular dystrophy (FSHD [MIM
158900]) is the third most common inherited muscular
dystrophy, with an estimated frequency of 1 in 20,000
(Padberg 1982). The disease is foremost characterized
by a progressive and often asymmetrical weakness and
wasting of the facial, shoulder, and upper-arm muscles.
Generally, FSHD displays a characteristic gradual spread
of muscle involvement, starting in the face and slowly
progressing to the shoulder and upper-arm musculature
and to the abdominal and foot-extensor muscles. Ex-
tramuscular involvement is also reported for FSHD,
since approximately half of the patients present with
subclinical high-tone hearing loss and retinovasculopa-
thy (Padberg 2004). In some severely affected patients
of Japanese origin, mental retardation and epilepsy are
reported (Funakoshi et al. 1998; Miura et al. 1998).
Males are typically more severely affected than females,
and there is a wide clinical inter- and intrafamilial var-
iability of the disease, with ∼20% of patients eventually
becoming wheelchair-bound and with an equal fre-
quency of nonpenetrant gene carriers (Padberg et al.
1991; Zatz et al. 1998).
The disease displays an autosomal dominant mode
of inheritance, with the vast majority of familial cases
linked to a genetic lesion in the subtelomere of chro-
mosome 4q (4qter) (Wijmenga et al. 1990, 1992). Some
familial cases have been reported that do not link to
4qter, but a second locus for FSHD has yet to be iden-
tified (Gilbert et al. 1992, 1993; Tim et al. 2001). Al-
though, in the early 1990s, FSHD was one of the first
diseases to be linked to a genomic locus by use of mi-
crosatellite repeat markers, the pathogenomic mecha-
nism underlying FSHD is still largely unresolved. In con-
trast to most monogenic disorders, in which the genetic
lesion typically affects the structure or function of a
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specific disease gene, there is increasing evidence that
FSHD is caused by a complex epigenetic mechanism
involving the contraction of a subtelomeric macro-
satellite repeat. Thus, it is likely not the structure but
rather the (spatiotemporal-restricted) transcriptional
control of one or more disease genes that is perturbed
in FSHD as a result of repeat-contraction–mediated
chromatin alterations. This review focuses on the recent
advances in understanding the cause and consequence
of the repeat-array contraction and the different mech-
anistic disease models that have emerged from these
studies.
FSHD, a Macrosatellite Repeat-Contraction Disease
One of the most prominent features of the subtelomere
of chromosome 4q is a large polymorphic repeat struc-
ture consisting of 1–100 KpnI units, designated “D4Z4”
(van Deutekom et al. 1993; Hewitt et al. 1994). These
units, each 3.3 kb in size, are ordered in a head-to-tail
orientation and show very little sequence diversity. In
95% of patients with FSHD, the D4Z4 repeat is con-
tracted to an array of 1–10 units (Wijmenga et al. 1992;
van Deutekom et al. 1993), and, apparently, at least one
unit of D4Z4 is required to develop FSHD, since mon-
osomy of 4q does not cause FSHD (Tupler et al. 1996).
There is a rough and inverse relationship between clin-
ical severity and the residual repeat size, with the smallest
repeats causing the most severe phenotypes (Lunt et al.
1995; Tawil et al. 1996).
D4Z4 repeats are typically visualized on Southern
blots of genomic DNA after digestion with EcoRI and
hybridization with probe p13E-11. Probe p13E-11 does
not recognize the repeat proper but a locus (D4F104S1)
just proximal to the repeat, within the D4Z4-containing
EcoRI fragment (Wijmenga et al. 1992; van Deutekom
et al. 1993). Because of the large size of the repeat (10–
38 kb in disease alleles and 138–350 kb in healthy al-
leles), Southern blots after conventional linear gel elec-
trophoresis typically only allow visualization of the
disease allele, and alleles of 150 kb comigrate at the top
of the gel. Therefore, for complete assessment of D4Z4
repeats, pulsed-field gel electrophoresis (PFGE) is re-
quired (Lemmers et al. 2004b).
The D4Z4 unit has been completely sequenced and
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shows some peculiar features (Hewitt et al. 1994; Wi-
nokur et al. 1994; Lee et al. 1995). First, D4Z4 contains
an ORF encoding a putative homeobox protein called
“DUX4.” Native transcripts of DUX4 have never been
identified, although recent data show some evidence of
the presence of a DUX-related protein, specifically in
FSHD myoblasts (Hewitt et al. 1994; Lyle et al. 1995;
Gabriels et al. 1999; Coppee et al. 2004). In addition,
D4Z4 harbors two classes of repetitive DNA—the GC-
rich low-copy repeats hhspm3 and LSau, both of which
are found predominantly in heterochromatic domains
of the genome (Hewitt et al. 1994). Furthermore, D4Z4
is unusually GC rich, with no fewer than 290 CpG
dinucleotides and with a GpC:CpG ratio of 0.7. D4Z4
is not restricted to chromosome 4; perfect arrays of
D4Z4 units can also be detected on chromosome 10q
(see the “Unique Linkage of FSHD to Chromosome
4” section) (Bakker et al. 1995; Deidda et al. 1995),
whereas additional sequences homologous to D4Z4 can
be identified on many heterochromatic loci, such as
those of the short arms of acrocentric chromosomes and
the pericentromeric region of chromosome 1q, where
they are often interspersed by other (satellite) repeats
(Lyle et al. 1995; Ballarati et al. 2002).
Unique Linkage of FSHD to Chromosome 4
The subtelomeric location of the D4Z4 repeat adds sev-
eral intriguing findings to the pathogenic mechanism of
FSHD. Subtelomeres define the proterminal ends of
chromosomes and are composed of patchworks of ge-
nomic segments that are spread over many nonhomo-
logous chromosome ends as a result of ectopic recom-
bination and duplication events (Mefford and Trask
2002). Subtelomeres may be organized in a proximal
domain that is shared with a subset of nonhomologous
chromosomes and a distal domain shared with almost
all chromosome ends. The proximal and distal domains
are often separated by an imperfect telomere repeat
(Flint et al. 1997).
The D4Z4 repeat is localized in the proximal sub-
telomeric domain, which, as a result of an ancient du-
plication, is also present at the end of chromosome 10q
(Bakker et al. 1995; Deidda et al. 1995). As a con-
sequence, 10qter harbors a highly homologous and
equally polymorphic repeat array at the same chro-
mosomal position as on chromosome 4. Interestingly,
10% of chromosomes 10 also carry an FSHD-sized re-
peat (Bakker et al. 1995, 1996). However, in contrast
to the D4Z4 repeat on chromosome 4qter, repeat con-
tractions on 10qter have never been reported in studies
of FSHD.
Through the combination of restriction enzymes dif-
ferentially recognizing chromosomes 4– and 10–derived
repeat units and allele separation by PFGE (Deidda et
al. 1996; Lemmers et al. 2001), the behavior of this
macrosatellite repeat is now well studied in healthy and
FSHD populations. Owing to subtelomeric localization,
translocations of chromosome 4– and 10–derived units
are encountered in the Dutch population with an equal
frequency of 10% (van Deutekom et al. 1996; van Over-
veld et al. 2000). These translocations have been ob-
served in other populations (Matsumura et al. 2002)—
albeit at somewhat different frequencies—which sug-
gests that de novo translocations are universal but rare.
Translocated repeat arrays are not always homogeneous
but are often composed of clusters of chromosome 4–
derived and chromosome 10–derived repeat units (Lem-
mers et al. 1998; van Overveld et al. 2000). Despite this
plasticity, contracted repeats on chromosome 10 have
never been associated with FSHD, whereas the exact
composition of the contracted repeat array on 4qter
(i.e., whether it is derived from chromosome 4, 10, or
both) seems to be irrelevant to the development of
FSHD. It is interesting, however, that chromosome 4–
derived translocated repeat arrays on chromosome 10
tend to be homogeneous, whereas the inverse translo-
cations on chromosome 4 are almost always composed
of heterogeneous clusters of chromosome 4– and 10–
derived repeat units (van Overveld et al. 2000). The
cause for this difference in homogeneity is currently
unknown but may relate to a directional mutation
mechanism.
Subtelomeric Variation Distal to D4Z4
It was recently observed that two allelic variants of the
4q subtelomere exist (van Geel et al. 2002), which adds
to the complexity of the pathogenesis of FSHD. Large
allelic variations of subtelomeric domains may not be
uncommon. For example, for chromosome 16pter, three
variants have been reported that differ in size by several
hundred kilobases (Wilkie et al. 1991). On the basis of
some sequence variations distal to D4Z4, within differ-
ent YAC clones originating from chromosome 4, two
allelic variants were identified and were designated
“4qA” and “4qB” (van Geel et al. 2002). Subsequent
studies showed that both alleles are almost equally com-
mon in the general population but that FSHD alleles are
always the 4qA type. Furthermore, it was demonstrated
that both chromosomes display an equal propensity to
rearrange, and it was thus hypothesized that, in addition
to a contraction of D4Z4, additional elements in cis are
necessary to cause FSHD (4qA) or to prevent it (4qB)
(Lemmers et al. 2002). This hypothesis was recently cor-
roborated by the demonstration that FSHD-sized repeat
arrays on 4qB chromosomes, indeed, do not cause FSHD
(Lemmers et al. 2004d). It is confusing that all chro-
mosome 10 ends are of the 4qA type, making it more
difficult to explain easily the unique linkage of FSHD to
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Figure 1 Schematic presentation of the primary genetic defect of FSHD. Polymorphic arrays of D4Z4 units (triangles) are located in the
subtelomeres of chromosomes 4q (red) and 10q (blue). On chromosome 10, this array may vary between 1 and 100 units without pathological
consequences (n p number of units). On chromosome 4, however, repeat arrays in the range of 1–10 units cause FSHD, but only when the
contraction is in cis with the subtelomeric variant 4qA, which contains beta satellite repeats (red rectangle), not the 4qB variant. The beta
satellite repeats are also present in the 10q subtelomere (blue rectangle).
4qA. Figure 1 summarizes all known genetic require-
ments for development of FSHD.
The distal ends of both alleles are only partly se-
quenced, and, therefore, the exact differences are un-
known. The most prominent difference is the presence
of a 6.2-kb beta satellite repeat directly distal to D4Z4
on 4qA chromosomes (van Geel et al. 2002). Beta sat-
ellite repeats are 68-bp repetitive elements that are
found mostly on the pericentromeric domains of the
acrocentric chromosomes in which they probably, like
alpha satellite repeats, fulfill a structural role (Agresti
et al. 1989; Vogt 1990; Lee et al. 1997). Given the
epigenetic disease mechanism, it is postulated that the
presence of this beta satellite repeat is essential for the
disease presentation, although it does not explain why
FSHD-sized repeats on chromosome 10qter with the
identical beta satellite repeat are nonpathogenic.
Detailed analysis of the D4Z4 repeat on 4qA, 4qB,
and 10q chromosomes showed some unexpected fea-
tures. First, the size distribution of the D4Z4 repeat is
not uniform but rather shows a multimodal distribution
with equidistant peaks of ∼65 kb, possibly reflecting a
higher-order chromatin architecture (van Overveld et
al. 2000). Second, the mean length of the repeat array
is different for the three chromosome ends. Whereas
D4Z4 repeats on 4qA chromosomes are, on average,
136 kb in size, repeats on 4qB chromosomes are 94 kb,
on average, and repeats on chromosome 10q are 75 kb,
on average (van Overveld et al. 2000; Lemmers et al.
2004c). The cause of this difference in mean size is cur-
rently unknown, but it suggests that, despite the high
frequency of translocated repeat arrays, interchromo-
somal recombination is rare.
Indeed, a detailed search for allele-specific polymor-
phisms revealed a PvuII polymorphism within D4Z4
that is not uniformly distributed over the repeats on
4qA and 4qB chromosomes (Lemmers et al. 2004c).
Whereas approximately one-third of all most-proximal
(i.e., first) repeat units on 4qB chromosomes are sen-
sitive to PvuII, almost none of the proximal units of the
array on 4qA chromosomes carry this PvuII site. How-
ever, on both alleles, the D4Z4 units after the first unit
seem to be equally sensitive to PvuII. This, and other
polymorphisms studied, showed that regions proximal
and distal to D4Z4 are in strong linkage disequilibrium
and that, although internal units of D4Z4 on 4qA and
4qB chromosomes are fairly well homogenized, recom-
bination between 4qA and 4qB of sequences flanking
D4Z4 is not frequent.
Timing and Mechanism of D4Z4 Contraction
D4Z4 displays a considerable mitotic instability. In the
Dutch population, 3% of individuals are carriers of a
mitotic repeat contraction or expansion on either chro-
mosome 4 or 10 (van Overveld et al. 2000). The mech-
anism by which D4Z4 mitotically rearranges is well
studied in de novo kindreds with FSHD. Although germ-
line mosaicism has been only sporadically reported in
studies of FSHD (Griggs et al. 1993; Weiffenbach et al.
1993), almost half of de novo FSHD cases arise through
a mitotic rearrangement, either in the unaffected carrier
parent of an affected nonmosaic child or in the affected
individual (van der Maarel et al. 2000). In these mosaic
individuals, there seems to be a relationship between the
severity of the disease and the combination of the resid-
ual repeat size and the proportion of cells carrying the
disease allele. The gender difference in clinical severity
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is well reflected in mosaic individuals. Whereas females
are mostly unaffected carriers of a mosaic FSHD allele,
males, when carrying a comparable mosaic allele com-
plement, are more often affected (van der Maarel et al.
2000). This predominance of asymptomatic female car-
riers of a somatic contraction has been reported re-
peatedly (Zatz et al. 1995; Kohler et al. 1996; van der
Maarel et al. 2000), although a gender difference in clin-
ical severity could not be confirmed in a study of mosaic
and nonmosaic Japanese individuals (Goto et al. 2004).
Initially, somatic mosaicism was only described in un-
affected carrier parents of nonmosaic affected children
(e.g., see Upadhyaya et al. [1995] and Kohler et al.
[1996]). However, with the increased resolution of
PFGE, somatic mosaicism was also detected—with
equal frequency—in affected de novo patients. Indeed,
it was recently demonstrated that the conventional lin-
ear gel-based Southern blot detection for FSHD alleles,
a standard procedure in most diagnostic centers, often
fails to detect somatic mosaicism for the disease allele
in mosaic patients, since it relies fully on a (minor) de-
creased signal intensity for mosaic alleles and not on
the presence of 14 alleles (Lemmers et al. 2004a).
The presence of only five alleles in the genomes of
mosaic individuals suggests that most mitotic rearrange-
ments occur by a single gene-conversion event without
crossover. Such mitotic gene conversion, by definition,
results in the presence of two cell populations: one car-
rying the unchanged parental donor allele and one car-
rying a rearranged acceptor allele. The exact mechan-
ism by which the D4Z4 repeat mitotically contracts
was studied in further detail in a cohort of mosaic
Dutch kindreds with FSHD. This demonstrated that,
most likely, D4Z4 rearranges by a synthesis-dependent
strand-annealing mechanism without crossover. How-
ever, gene conversion with crossover was also detected,
with an unexpectedly high frequency. In three-quarters
of the mosaic individuals, two cell populations were
identified by the presence of five alleles (two alleles de-
rived from chromosome 10, one nonrearranged allele
derived from chromosome 4, and two alleles with re-
duced intensity derived from chromosome 4 prior to
and after gene conversion without crossover). However,
the remainder of mosaic individuals had two cell pop-
ulations carrying distinct mitotically rearranged alleles
derived from gene conversions with crossover. These
individuals sometimes have, in addition, a cell popu-
lation that carries the unchanged alleles prior to rear-
rangement (fig. 2). On the basis of these studies, it was
suggested that mitotic contractions of D4Z4 likely occur
within the first few cell divisions after fertilization. Fur-
ther analysis of polymorphisms within, proximal to,
and distal to D4Z4 showed that the preferred partner
for these gene conversions is the sister chromatid rather
than the homologous chromosome (Lemmers et al.
2004c). This finding was rather unexpected, since, in a
previous study, it was shown that mosaic individuals
have an increased frequency of translocated chromo-
some 4–derived repeats on chromosome 10, suggesting
that the presence of supernumerary identical—but not
homologous—repeats adds to the mitotic instability of
D4Z4 (van der Maarel et al. 2000). Similar findings
were recently confirmed in another population (Wu et
al. 2004). In line with this model, there seems to be a
slight but significant increased pairing frequency, at in-
terphase, of 4qter and 10qter domains in cultured lym-
phocytes from patients with FSHD (Stout et al. 1999).
Interestingly, it was recently described that the sub-
telomeric domains of chromosomes 4 and 10 occupy
distinct territories in the nucleus. Of all subtelomeres
studied, 4qter displayed the highest preference for the
nuclear periphery, whereas the 10q subtelomeres were
much more localized to the interior of the nucleus
(Masny et al. 2004). This finding was recently corrob-
orated by another study (Tam et al. 2004), in which the
preferential localization of 4q35 in the heterochromatic
nuclear periphery was suggested to be related to gene
expression profiles along chromosome 4, with the sub-
telomere of chromosome 4q being substantially poorer
in transcriptional activity than 4p, which was located
more interiorly. Apart from being the first structural
(and perhaps first functional) difference between chro-
mosomes 4 and 10, this observation may provide an
explanation for the preferred partner for recombination
given the increased frequency of 4-derived repeats on
chromosome 10 in mosaic individuals. It is becoming
increasingly evident that chromosomes occupy distinct
territories in the mammalian nucleus, and there is some
evidence that the spatial organization is largely retained
after mitosis (Gerlich et al. 2003). Could it be possible
that the presence of translocated chromosome 4–de-
rived D4Z4 repeats on chromosome 10 has a subtle
impact on integrity and faithful transmission during
early embryogenesis? Clearly, the issue is still largely
unsettled, but, as a first step, it would be interesting to
investigate whether the presence of translocated repeats
on either chromosome influences their nuclear locali-
zation and their relative positions, with respect to each
other, in dividing and nondividing cells. Tam et al.
(2004) demonstrated that the preference for the nuclear
periphery is an intrinsic property of 4qter, since the pres-
ence of 4 Mb of 4qter sequences on a derivative chro-
mosome X in a cell line with a 4;X translocation causes
a more peripheral localization of this chromosome.
Nevertheless, both studies suggested a region directly
proximal to D4Z4 as responsible for the perinuclear
localization (Masny et al. 2004; Tam et al. 2004). More-
over, it should be realized that, although mitotic rear-
rangements of D4Z4 are fairly common in the general
population, in individuals they seem to be restricted to
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Figure 2 Mechanism of mitotic contractions of D4Z4 in FSHD. A, Generally, repeat rearrangements are induced by double-strand breaks,
in this case within D4Z4 (triangles). Break repair through gene conversion with crossover (GCCO) or without crossover (GCCO) requires
the pairing of the damaged DNA strand (acceptor indicated by unblackened triangles) with the homologous donor (blackened triangles). In
FSHD, the sister chromatids are likely the preferred partners in this process. By unequal pairing, the repair of repetitive DNA by GCCO or
by GCCO is associated with an expansion or contraction of the repeat. B, Schematic representation of somatic mosaicism encountered in
FSHD. D4Z4 alleles are visualized in DNA digested by EcoRI (E) and hybridized by probe p13E-11. Chromosome 4 alleles (red) are distinguished
from chromosome 10 alleles (blue) by their resistance to BlnI (B). Chromosome 4–derived EcoRI/BlnI fragments are 3 kb smaller because of
a single internal BlnI site. GCCO causes the contraction (or expansion) of a single allele, and the donor alleles remain unchanged. Mosaic
(m) alleles are recognized by their reduced signal intensity (dashed lines). During GCCO, the size of the donor and acceptor alleles are changed.
When crossover occurs before the first zygotic division, this yields two cell populations with the newly formed donor and acceptor allele (GCCO
1). When it occurs in zygotic divisions after the first division, a population of cells, in addition to the two newly formed alleles, will be present
carrying the ancestral allele (GCCO 2).
a single event, most likely during early embryogenesis.
Therefore, it is tempting to speculate that specific char-
acteristics of early cell division, such as the spatial nu-
clear separation of paternal and maternal haploid ge-
nomes (Mayer et al. 2000), are contributing to the
mitotic D4Z4 instability.
Irrespective of the exact mechanism, partial deletions
of the D4Z4 repeat array are not always confined to
the repeat proper. In 1% of sporadic and familial pa-
tients, the partial D4Z4 deletion extends in the proximal
direction and includes the probe region D4F104S1
(Lemmers et al. 1998, 2003). Proximal deletions can
include up to 60 kb proximal to D4Z4, and the inverted
D4Z4 repeat unit (D4S2463) 40 kb proximal to D4Z4
might play a role in the mutational mechanism. Typi-
cally, patients with these deletions present a classic
FSHD phenotype. Therefore, with the standard DNA
diagnosis of FSHD performed by use of probe p13E-
11, the absence of an FSHD-sized chromosome 4–de-
rived D4Z4 fragment does not necessarily exclude the
involvement of this region in these cases of FSHD. With
the recognition of proximal extended deletions, addi-
tional diagnostic protocols have been developed to ad-
dress this issue, including the dosage test that quantifies
specific chromosome 4– and chromosome 10–derived
restriction fragments (van der Maarel et al. 1999),
PFGE, and the use of a distal 4qA probe as an alter-
native to p13E-11 (Lemmers et al. 2003).
380 Am. J. Hum. Genet. 76:375–386, 2005
Epigenetic Consequences of D4Z4 Contractions
Because contractions of D4Z4 did not seem to disturb
the structure of a specific disease gene, it was soon hy-
pothesized that chromatin conformational changes
could underlie the disease mechanism of FSHD. These
conformational changes, in turn, would lead to inap-
propriate downregulation or upregulation of one or
more genes within or in the close vicinity of the D4Z4
repeat.
Since C5 methylation of cytosine is the most common
modification of mammalian DNA and is known to be
involved in development, X-chromosome inactivation,
imprinting, and gene silencing (Robertson and Wolffe
2000), efforts were undertaken to investigate the DNA
methylation of D4Z4. In an initial survey focusing on
several different methylation sites in the repeat, D4Z4
was found to be highly methylated in a limited set of
normal and FSHD lymphoblasts, as well as in somatic
tissues, including skeletal muscle (Tsien et al. 2001). In
a more recent study that analyzed the DNA methylation
in lymphoblast DNA from a much larger cohort of pa-
tients and controls by a different strategy, D4Z4 was
shown to be significantly hypomethylated at the disease
allele in patients with FSHD (van Overveld et al. 2003).
While, in control individuals, D4Z4 methylation levels
of ∼50% were detected at each CpG dinucleotide tested,
these methylation levels were reduced by half in disease
alleles of patients and nonpenetrant gene carriers. This
observation was confirmed in a limited set of control
and FSHD muscle DNA. Importantly, in a small set of
patients with an FSHD phenotype but no contraction
of the D4Z4 repeat (non–4q-linked FSHD), D4Z4 was
also hypomethylated, suggesting that, in non–4q-linked
FSHD, the disease mechanism also acts through D4Z4,
albeit unrelated to the contraction. In contrast to 4q-
linked patients in whom only the contracted allele was
hypomethylated, non–4q-linked patients showed hy-
pomethylated D4Z4 on both chromosome 4q ends. The
different outcomes of both methylation studies may be
explained by differences in sample size, the method em-
ployed, and the methylation-sensitive restriction en-
zymes used.
Interestingly, strong hypomethylation of D4Z4 was
first reported in immunodeficiency–centromeric insta-
bility–facial anomalies syndrome (ICF syndrome [MIM
242860]), an autosomal recessive disorder characterized
by immunodeficiency, facial anomalies, and subtle de-
velopmental delay (Kondo et al. 2000). ICF syndrome
is a very rare disorder (∼35 patients, primarily Euro-
pean, have been described) that invariably presents with
abnormalities of the juxtacentromeric heterochromatin
of chromosomes 1 and 16 in mitogen-stimulated lym-
phocytes. These chromosomes have long juxtacentrom-
eric heterochromatin regions of satellite DNA. ICF is
caused by mutations in the catalytic domain of the
DNMT3B gene that reduce, but do not abolish, its DNA
methyltransferase activity (Xu et al. 1999). As a result,
DNA of patients with ICF shows reduced methylation
at specific repetitive DNA sequences, including the peri-
centromeric Sat2, Sat3, and NBL2 repeats at the afore-
mentioned chromosomes (1 and 16) and D4Z4 repeats
at the subtelomeres of chromosomes 4q and 10q (re-
viewed by Ehrlich [2003]). Although hypomethylation
of D4Z4 is observed in 4q-linked and non–4q-linked
FSHD, ICF does not present with a myopathic phe-
notype. It may be argued that the lack of muscular
dystrophy in patients with ICF may be due to the se-
verity of the disorder and, accordingly, to the relative
young age at which these patients usually die, whereas
FSHD typically starts in the 2nd decade of life. How-
ever, two observations argue against this explanation
for the absence of myopathy in ICF: the occurrence of
the infantile form of FSHD, starting in the 1st decade
of life and the absence of any subclinical myopathic
features in ICF, even in relatively old patients with un-
usual mild ICF syndrome due to high residual DNA
methyltransferase activity of DNMT3B.
One obvious explanation for the lack of muscular
dystrophy in patients with ICF may relate to the allelic
variation of 4qter distal to D4Z4 and by the absence
of 4qA alleles in patients with ICF syndrome. However,
analysis of a limited number of patients also showed
the presence of 4qA in some of these patients (authors’
unpublished results).
In patients with ICF, the D4Z4 hypomethylation is
much more pronounced than in patients with 4q-linked
FSHD and, rather than hypomethylation being re-
stricted to a single chromosome, the alleles on chro-
mosomes 4 and 10 are equally hypomethylated. Al-
though similar low levels of methylation were found at
both chromosome 4q ends, and possibly at chromosome
10, in patients with non–4q-linked FSHD, these patients
do not suffer from a defect in DNMT3B (authors’ un-
published results).
The proposed heterochromatic nature of 4qter was
further studied by means of chromatin immunoprecip-
itation assays. Analysis of the histone H4 acetylation
levels for a region immediately adjacent to D4Z4 dem-
onstrated that 4qter had properties of unexpressed eu-
chromatin, rather than constitutative heterochromatin,
in fibroblasts, lymphoblastoid cell lines, and mononu-
clear blood cells of controls and FSHD cases (Jiang et
al. 2003). Moreover, on the basis of histone acetylation
studies and semiquantitative expression analyses of
genes on chromosome 4qter, there was no evidence of
a spreading of heterochromatinization emanating
from the D4Z4 repeat. In a follow-up study, other mark-
ers of heterochromatin were evaluated by cytogenetic
and immuno-FISH analysis of healthy and FSHD myo-
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blasts. This again suggested that 4qter did not resemble
constitutive heterochromatin, in either patient or con-
trol cells. More specifically, the 4qter region did not
seem to colocalize with 4′-6-diamidino-2-phenylindole
(DAPI)–bright foci, or with regions enriched in hetero-
chromatin protein-1a or histone H3 trimethylated at
lysine 9. Finally, the replication timing of 4qter was
found to be very close to that of unexpressed euchro-
matin, and there was no indication of a change in rep-
lication timing in FSHD cells (Yang et al. 2004).
Disease-Mechanism Models for FSHD
Over the past decade, several models have been put for-
ward to explain the disease mechanism in FSHD. These
are schematically represented in figure 3. Originally,
when it became clear that the structure of the disease
gene was not compromised and that D4Z4 shared prop-
erties of heterochromatic sequences, it was postulated
that D4Z4 and surrounding sequences would be packed
as heterochromatin and that partial loss of the D4Z4
repeat would lead to local chromatin relaxation (i.e.,
loss of heterochromatinization) and, consequently, to the
transcriptional upregulation of genes near D4Z4, pos-
sibly in a distance-related manner (cis-spreading model
in fig. 3A) (Hewitt et al. 1994; Winokur et al. 1994).
Alternatively, it was proposed that D4Z4 acts as an in-
sulator, separating heterochromatic telomeric sequences
distal to D4Z4 from euchromatic sequences more up-
stream (van Deutekom 1996). Contracted arrays would
not be able to completely separate both domains, and,
consequently, heterochromatic spreading into proximal
sequences would silence subtelomeric genes in cis (in-
sulator model in fig. 3B). Although recent molecular data
do not fully support either of these models, it is too early
to completely refute these possibilities.
Evidence for the cis-spreading model was provided
by the identification of a repressor complex that binds
to a specific sequence in D4Z4 (Gabellini et al. 2002).
In muscle of patients with FSHD, a distance-dependent
transcriptional upregulation was found for three 4qter
genes (FRG2, FRG1, and ANT1). Moreover, the mag-
nitude of upregulation of the gene closest to the D4Z4
repeat seemed to be inversely related to the residual size
of the D4Z4 repeat in FSHD muscle. This repressor
complex consists of YY1, a transcription factor that
can act as transcriptional activator or repressor; the
chromatin architectural protein HMGB2; and the
RNA-binding protein nucleolin, which is involved in
transcriptional control of ribosomal RNA and in ri-
bogenesis. In cell culture, depletion of any of these com-
ponents of the repressor complex was shown to upreg-
ulate FRG2, the gene closest to D4Z4. However, in
several independent follow-up studies, the upregulation
of these 4qter genes in FSHD muscle could not be con-
firmed by semiquantitative real-time PCR or array stud-
ies (Jiang et al. 2003; Winokur et al. 2003; R. J. L. F.
Lemmers, T. Rijkers, R. R. Frants, and S. M. van der
Maarel, unpublished results).
In the meantime, other models have been put forward
to explain FSHD. First, contraction of D4Z4 may lead
to inappropriate gene expression by a cis-looping model
(fig. 3C) (Jiang et al. 2003). According to this model,
long-distance loops between D4Z4 and its target gene(s)
occur only when the formation of normal D4Z4 intra-
array loops are impaired by chromatin constraints due
to D4Z4 contraction. The observation that the size dis-
tribution of D4Z4 repeats is multimodal, with equidis-
tant peaks 65 kb apart, may support a model in which
normal-sized D4Z4 repeats form intra-array loops (van
Overveld et al. 2000). Moreover, somewhat similar ob-
servations have already been reported for the regulation
of the b-globin gene cluster by its locus control region
and by the observation of loop-like chromatin-chro-
matin interactions of several megabases by FISH anal-
ysis (Volpi et al. 2000).
The most recent model is one of disturbed nuclear
localization (nuclear organizing model in fig. 3D) and
is not necessarily mutually exclusive of the cis-looping
model (Masny et al. 2004). Expression analysis of 4qter
genes remains controversial, and no consistent tran-
scriptional upregulation of 4qter genes has been iden-
tified by array and semiquantitative RT-PCR studies to
support a cis-spreading effect (Jiang et al. 2003; Wi-
nokur et al. 2003; R. J. L. F. Lemmers, T. Rijkers, R.
R. Frants, and S. M. van der Maarel, unpublished re-
sults). Therefore, since the mammalian nucleus is highly
compartmentalized, with individual chromosomes oc-
cupying distinct territories most likely reflecting their
gene density, transcriptional activity, replication timing,
and chromosome size (Sun et al. 2000; Tanabe et al.
2002), the organization of 4qter in the nucleus was
studied. As described above, 4qter largely occupies a
peripheral territory in the nucleus, independent of cell
type and chromosome-territory effects. Importantly, this
localization seems to be dependent on the integrity of
the nuclear lamina, since this peripheral localization of
4qter is lost in cells deficient of lamin A/C (Masny et
al. 2004). Interestingly, several neuromuscular disor-
ders, the so-called laminopathies, arise from deficiencies
in nuclear lamina proteins, including lamin A/C and
emerin (reviewed by Maraldi et al. [2004]). By contrast,
10qter is more localized to the interior of the nucleus,
suggesting that these chromosome ends are functionally
different. Moreover, it is not D4Z4 itself but rather se-
quences proximal to D4Z4—which are not present on
chromosome 10—that mediate the interaction with the
nuclear lamina (Masny et al. 2004). This may explain
the chromosome 4 specificity of FSHD. In this study
Figure 3 Different models to explain the epigenetic disease mechanism of FSHD. The location of the most well-studied genes (FRG1,
FRG2, and ANT1) are indicated. A, In the cis-spreading model, the long D4Z4 repeat (triangles) and nearby sequences share features of
heterochromatin. Upon contraction, a local chromatin relaxation (blue gradiation) causes the transcriptional upregulation of 4qter genes (red
boxes for downregulated and green boxes for upregulated genes) in a distance-dependent manner, possibly through the action of the D4Z4
repressor complex. B, In the insulator model, D4Z4 acts as a spacer between heterochromatic sequences distal to the D4Z4 repeat and proximal
euchromatic sequences. Upon contraction, this insulator function is incomplete, allowing heterochromatinization (wave) of proximal sequencing
and transcriptional downregulation of genes within this region. C, The cis-looping model postulates that normally intra-array loops in arrays
111 units prevent the interaction of D4Z4 with genes in cis at a large distance. Disruption of this interaction may cause inappropriate gene
expression by long-range interaction with D4Z4. D, Finally, the nuclear organization model predicts that the interaction of 4qter with the
nuclear lamina, in which chromatin and transcription factors (purple circles) are tethered, is perturbed in FSHD. This perturbation, in turn,
may lead to a misbalance of chromatin and transcription factors at 4qter and unrelated loci.
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(Masny et al. 2004), no disturbed localization was ob-
served for the disease allele in myoblasts of patients with
FSHD. Since no difference was observed in the locali-
zation of healthy and disease chromosomes, it was pos-
tulated that the interaction between 4qter and the
nuclear envelope is different because of an altered
recruitment of chromatin and transcription factors at
the nuclear lamina. Independently, Tam et al. (2004)
reported largely similar observations. They demon-
strated that intrinsic properties of 4qter are necessary
and sufficient to localize this subtelomeric domain in
the nuclear periphery and suggested a role for D4Z4 in
regulating the local heterochromatic state (Tam et al.
2004). According to this study, D4Z4 may operate as
a silencer or insulator separating distal heterochromatin
from proximal genes.
Conclusions
During the past 5 years, our understanding of FSHD has
accelerated enormously. Regardless of the exact molec-
ular mechanism, the unifying theme that emerges is a
D4Z4 contraction–mediated chromatin conformational
change at 4qter as the primary pathogenic mechanism.
In turn, this conformational change may cause the in-
appropriate expression of one or more disease genes,
not necessarily in cis with the contracted D4Z4 repeat.
Several genes have been proposed on the basis of their
localization, evolutionary conservation, and function,
including FRG1, FRG2, ANT1, and ALP, but conclusive
evidence for their involvement is not currently available.
The development of cellular and animal models for this
disease will undoubtedly prove to be of critical impor-
tance in further understanding this enigmatic disease.
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